Fundraising FoxNucleix
9 known investors
Find your way into Nucleix
Sign up to see every warm intro you have to Nucleix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nucleix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection. It serves the medical diagnostics and biotechnology market.
Founders & leadership
Investors · 9
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: RA Capital's portfolio page · funding news · sdbj.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: funding news · sdbj.com · Not right? Tell us
How we know: funding news · sdbj.com · Not right? Tell us
How we know: funding news · sdbj.com · Not right? Tell us
How we know: funding news · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$55M disclosed across 1 of 2 rounds · 2021–2022
- $55MraisedApr 2021 · 3 sources
RA Capital Management (lead), BlackRock, Lilly Asia Ventures, LYFE Capital, MILFAM
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Nucleix do?
- Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection. It serves the medical diagnostics and biotechnology market.
- Who are Nucleix's investors?
- Nucleix's investors include Gefen Capital, OrbiMed, RA Capital, Aurum Ventures MKI, BlackRock, Lilly Asia Ventures, LYFE Capital, Sands Capital Ventures.
- How much funding has Nucleix raised?
- Nucleix has disclosed $55M raised across 1 of its 2 known rounds.